22
May
May
Can you present Pikralida? We are a company operating as part of a hybrid business model. On the one hand, we focus on developing innovative therapies for unsatisfied medical needs, and on the other hand we offer services of a professional contract of contract research (CRO) for biotechnology and pharmaceutical companies. Our developmental efforts focus […]